Our Financials & Outlook
We look forward to all that’s to come in 2021, as we continue building on our strengths to reimagine the future.
2020 financial results reflect the downturn in the travel industry and the great progress made across our R&D pipeline.
Shareholder structure (January 2021)
Our capital strategy is a combination of non-dilutive funding sources and equity capital to finance the development of the Company’s vaccine candidates.
In 2021, Valneva expects to achieve major R&D milestones while increasing R&D investments in its three late-stage product candidates.